Table 1.
Tumor | Number of Samples | Spearman r | p Value |
---|---|---|---|
Acute myeloid Leukemia | 197 | 0.7 | <0.0001 |
Adrenocortical carcinoma | 92 | 0.87 | <0.0001 |
Bladder urothelial carcinoma | 413 | 0.63 | <0.0001 |
Brain low grade glioma | 530 | 0.94 | <0.0001 |
Breast cancer invasive | 1100 | 0.85 | <0.0001 |
Cholangiocarcinoma | 35 | 0.79 | <0.0001 |
Colorectal adenocarcinoma | 382 | 0.47 | <0.0001 |
Glioblastoma multiforme | 166 | 0.71 | <0.0001 |
Hepatocellular carcinoma | 373 | 0.82 | <0.0001 |
Head and Neck Squamous cell carcinoma | 522 | 0.46 | <0.0001 |
Kidney renal clear cell carcinoma | 534 | 0.84 | <0.0001 |
Lung adenocarcinoma | 517 | 0.78 | <0.0001 |
Lung squamous cell carcinoma | 177 | 0.38 | <0.0001 |
Lymphoid neoplasm diffuse large B-cell lymphoma | 28 | 0.29 * | 0.0389 * |
Mesothelioma | 86 | 0.83 | <0.0001 |
Ovarian serous cystadenocarcinoma | 307 | 0.58 | <0.0001 |
Pancreatic adenocarcinoma | 179 | 0.81 | <0.0001 |
Pheochromocytoma and paraganglioma | 184 | 0.8 | <0.0001 |
Sarcoma | 262 | 0.77 | <0.0001 |
Skin cutaneous melanoma | 471 | 0.74 | <0.0001 |
Stomach adenocarcinoma | 415 | 0.6 | <0.0001 |
Testicular germ cell cancer | 156 | 0.62 | <0.0001 |
Thymoma | 120 | 0.77 | <0.0001 |
Thyroid carcinoma | 509 | 0.79 | <0.0001 |
Uterine corpus endometrial carcinoma | 177 | 0.52 | <0.0001 |
Uveal melanoma | 80 | 0.9 | <0.0001 |
Results generated by analyzing expression data deposited into TCGA database. r—Correlation coefficient; * Pearson correlation analysis.